Articles

Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia

Institute of Hematology “L. and A. Seràgnoli”, “S. Orsola-Malpighi” University Hospital, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy
Institute of Hematology “L. and A. Seràgnoli”, “S. Orsola-Malpighi” University Hospital, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy
Division of Cellular Biotechnologies and Hematology, University Sapienza, Rome, Italy
Chair of Hematology, University of Bari, Italy
Oncohematology Division, IRCCS Ca’ Granda -Maggiore Policlinico Hospital Foundation, Milan, Italy
Hematology Unit, Azienda Ospedaliera “Papa Giovanni XXIII”, Bergamo, Italy
Hematology Unit, “S. Eugenio” Hospital, Rome, Italy
Hematology Unit, “Pugliese-Ciaccio” Hospital, Catanzaro, Italy
Hematology Unit, Azienda Ospedaliera “Spedali Civili”, Brescia, Italy
Hematology Unit, Azienda Ospedaliero Universitaria “Città della Salute e della Scienza”, Torino, Italy
Chair of Hematology, Azienda Ospedaliero Universitaria Arcispedale “S. Anna”, University of Ferrara, Italy
Chair and Division of Hematology, Azienda Ospedaliero Universitaria Policlinico – V. Emanuele, University of Catania, Italy
Hematology Unit, Azienda Ospedaliera “Bianchi-Melacrino-Morelli”, Reggio Calabria, Italy
Department of Hematology, “Spirito Santo” Hospital, Pescara, Italy
Chair of Hematology, “Cattolica del Sacro Cuore” University, Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy
Division of Hematology and Bone Marrow Transplantation, Azienda Sanitaria Universitaria Integrata di Udine, Italy
Hematology Unit, “C. e G. Mazzoni” Hospital, Ascoli Piceno, Italy
Hematology Unit, Azienda Ospedaliera di Padova, University of Padova, Italy
Department of Medicine, Section of Hematology, University of Verona, Italy
Hematology Unit, “P. Giaccone” Hospital, Palermo, Italy
Institute of Hematology “L. and A. Seràgnoli”, “S. Orsola-Malpighi” University Hospital, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy
Division of Cellular Biotechnologies and Hematology, University Sapienza, Rome, Italy
Institute of Hematology “L. and A. Seràgnoli”, “S. Orsola-Malpighi” University Hospital, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy
Institute of Hematology “L. and A. Seràgnoli”, “S. Orsola-Malpighi” University Hospital, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy
Department of Biochemistry and Medical Biotechnologies, “Federico II” University, Napoli, Italy
Chair of Hematology, Department of Clinical and Biological Sciences, “S Luigi Gonzaga” University Hospital, University of Torino, Orbassano, Italy
Department of Hematology and Oncology “L. and A. Seràgnoli”, University of Bologna, Italy
Institute of Hematology “L. and A. Seràgnoli”, “S. Orsola-Malpighi” University Hospital, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy
Vol. 102 No. 9 (2017): September, 2017 https://doi.org/10.3324/haematol.2017.169532